ArriVent BioPharma, Inc.
AVBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001868279
No open-market purchases or sales by ArriVent BioPharma, Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.60B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q2 2025 vs. Q1 2025
How the institutions holding ArriVent BioPharma, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 83 | 1 | 99 | +17 |
| Shares | 29.1M | 118 | 33.6M | +4.55M (+15.7%) |
| Value | $539.3M | $2.18K | $732.0M | +$192.7M (+35.7%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (26)
Institutions that held ArriVent BioPharma, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (9)
Institutions that held ArriVent BioPharma, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Two Sigma Investments, LP | 41,381 | $765.1K |
| Marshall Wace, LLP | 35,851 | $662.9K |
| Alps Advisors Inc | 25,167 | $465.3K |
| Tudor Investment Corp Et Al | 15,293 | $282.8K |
| Dynamic Technology Lab Private Ltd | 14,379 | $266.0K |
| Corebridge Financial, Inc. | 13,803 | $255.2K |
| Manufacturers Life Insurance Company, The | 10,404 | $192.4K |
| Caitong International Asset Management Co., Ltd | 383 | $7.08K |
| Parkside Financial Bank & Trust | 20 | $370 |
Not filed for Q2 2025 yet (1)
Institutions that held ArriVent BioPharma, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Lindbrook Capital, LLC | 118 | $2.18K |